Dr. Kayla Baxendell is a pharmacist who is specialized in Ambulatory Care in Washington, Pennsylvania. Patients can reach her at 4081 Dividend Dr, Washington or contact her on 724-350-2391. Active license number of Dr. Kayla Baxendell is 03442508 for Ambulatory Care in Ohio. Dr. Kayla Baxendell is a licensed pharmacist who has demonstrated specialized knowledge and skill in the provision of integrated, accessible health care services by pharmacists and is accountable for addressing medication needs, developing sustained partnerships with patients, and practicing in the context of family and community.
Complete Profile:
Dr. Kayla Baxendell speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Kayla Baxendell are as mentioned below.
NPI Number:
1962237974
NPI Enumeration Date:
09 Sep, 2024
NPI Last Update On:
09 Sep, 2024
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Kayla Baxendell are as mentioned below.
Specialization
License Number
State
Status
Ambulatory Care
03442508
Ohio
Primary
Ambulatory Care
RP0013662
West Virginia
Secondary
Ambulatory Care
RP458305
Pennsylvania
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
4081 Dividend Dr, Washington, Pennsylvania
Zip:
15301-9216
Phone Number:
--
Fax Number:
--
Patients can reach Dr. Kayla Baxendell at 4081 Dividend Dr, Washington, Pennsylvania or can call on phone at 724-350-2391.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.